Another year, another successful Match! Please help us in congratulating our phenomenal incoming Cardiology Fellows!! 🫀We are extremely excited to have you join the family this summer! 🫶

The problem of #HCM awareness. Educating kids and patients through story. Steven Cooper Ankur Kalra Greenleaf Book Group Ahmad Masri Sei Iwai TCT Conference SCAI Matthew W Martinez Anju Bhardwaj MD FACC Anjali Owens Bristol Myers Squibb Cytokinetics Ozlem Bilen MD🫀FACC Bailey Ann Richardson a.co/d/8HfjbpT

Thank you 🙏🏽 everyone for all your messages & texts. We are safe & some of the lucky ones. Home is standing & we are safe People have been asking how to help. Here are some great places to give if you can We gathered what we could & volunteered w/ neighbors in our ‘hood ♥️

Promotion news 🎉 Thankful to mentors & colleagues 🙏🏻 Emory School of Medicine Emory Cardiology

Best cheerleader behind the scenes 💙

The honor of my career to lead this along with Aaron Baggish and Ben Levine. Experts around the world updating new #guidelines for sports for #athletes with heart disease. Major changes! #SDM #sportscards. Published today! American College of Cardiology American Heart Association ahajournals.org/doi/10.1161/CI…

Hypertrophic Cardiomyopathy Medical Society will host its annual #HCM meeting in partnership with AHA Science Friday November 7! (AHA Nov 8-10) ✅ register and get hotel through standard AHA portal ✅ abstracts published in Circulation ✅ combined reduced registration for both meetings ⬇️ details / New Orleans

Biykem Bozkurt, MD, PhD, FACC, is the 2025 Distinguished Fellow. A leader in heart failure and cardiac transplant care, her work in advancing global CV care and mentoring the next generation of CV professionals has been unparalleled. Congratulations, Dr. BiykemBozkurt! 👏 #ACC25

Grateful for the recognition 🫀#EmoryDoctorsDay2025 Emory School of Medicine Emory Healthcare EmoryCard

Unfortunate to see the ODYSSEY HCM trial not meeting its primary endpoints (KCCQ/pVO2). We will need to understand what drove the outcome here. news.bms.com/news/details/2… #cardiotwitter

We presented data on 48-72 week #whyCMR cardiac structure and function remodeling on aficamten in patients with #obstructive #HCM #ACC25 Lots of new data here including early vs delayed start, multiple evaluations, and mitral regurgitation assessment #cardiotwitter

1 year data on aficamten in the FOREST HCM trial are now published in JACC Journals pubmed.ncbi.nlm.nih.gov/40540987/ #CardioTwitter

ESC Congress LBT announced today! Delighted to present the results of the MAPLE-HCM trial in my hometown of MADRID! 🎉👏🏻🥳 Aficamten vs BB in monotherapy for obstructive HCM 🤔 Saturday 30th in Hot line session 2! Stay tunned!! ⏱️ CNIC Cardiología Puerta de Hierro🫀 Cytokinetics

Cardiology Fellowship applicants- I am looking for a new clinical research fellow for sports cardio to start July 2026! 2 yrs research, then gen cards! Apply to Emory School of Medicine Cardiology if interested! Austin Rim Jason Tso #sportscards

Presented at #ESCCongress: In symptomatic obstructive hypertrophic cardiomyopathy, aficamten improved oxygen uptake and heart function and decreased symptoms more than metoprolol, with a similar incidence of adverse events. Full MAPLE-HCM phase 3 trial results:

In symptomatic #nHCM, #mavacamten improved LV diastolic & LA function with modest LVH regression, but 1 in 5 demonstrated an #LVEF <50%, which reversed following therapy interruption. jacc.org/doi/10.1016/j.… #JACC #ESCCongress #WCCardio Milind Desai MD MBA

MAPLE HCM presented by Pablo Garcia-Pavia #ESC2025 #cardiotwitter

MAPLE-HCM Study: #Aficamten monotherapy compared to metoprolol monotherapy improves echocardiographic measures of cardiac structure and function in participants with symptomatic #oHCM jacc.org/doi/10.1016/j.… #ESCCongress #WCCardio #JACC #Echofirst Ahmad Masri Anne Dybro